CBST : Analysis & Opinions

  1. NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst ...

    December 18, 2014
    A report from Bloomberg indicated that the Shire is considering a potential acquisition of the NPS Pharma.
  2. Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx ...

    December 17, 2014
    It has been a relatively quiet week with the holiday season coming up though a few companies came out with important pipeline ...
  3. 4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst ...

    December 16, 2014
    Despite the sell-off in late March, the biotech sector bounced back thanks to important product approvals, mergers and acquisitions, ...
  4. Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

    March 25, 2014
    Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
  5. Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - ...

    January 8, 2014
    Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - Industry Outlook
  6. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  7. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
  8. Amgen and Other Healthcare Stocks Making Big Moves on October ...

    October 19, 2012
    The market is having a bad day so far: the Nasdaq has slipped 1.6%; the S&P 500 is trading down 1%; and the Dow is down ...
  9. 4 Heavily Shorted Stocks That Could Climb Higher

    January 3, 2012
    With the global equity markets still struggling, short-sellers have plenty of options. Here are four heavily shorted stocks ...
  10. Should Investors Circle Back To Cubist?

    July 19, 2011
    Cubist is hitting its targets, but it needs a more exciting pipeline.
  11. 4 Stocks The Money Managers Love

    September 7, 2009
    Now that mutual funds have filed their holdings with the SEC, we take a look at some money-manager favorites.
Trading Center